{"product_id":"harvard-3rd-annual-update-in-neuro-oncology-2023","title":"Harvard 3rd Annual Update in Neuro-Oncology 2023","description":"\u003cdiv class=\"title\"\u003e\n\u003cdiv class=\"section-heading-wrapper u-margin-l-ver\"\u003e\n\u003ch3\u003eHarvard 3rd Annual Update in Neuro-Oncology 2023\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 39 videos + 32 pdfs, size: 12.05 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: neurologists, oncologists, neurosurgeons, radiation oncologists, pathologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eNeuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day course, \u003cem\u003eAnnual Update in Neuro-Oncology\u003c\/em\u003e, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer.\u003cbr\u003e\u003cbr\u003eOur target audience will be the providers involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists and nurses.\u003cbr\u003e\u003ch3 class=\"variant-1\"\u003eWho Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSpecialty Physicians\u003c\/li\u003e\n\u003cli\u003eNurses, Pharmacists\u003c\/li\u003e\n\u003cli\u003ePhysician Assistants\u003c\/li\u003e\n\u003cli\u003ePsychologists\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"variant-1\"\u003eLearning Objectives\u003c\/h3\u003e\n\u003cbr\u003eUpon completion of this activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify the role of biomarkers in the diagnosis of pediatric and adult CNS and PNS tumors.\u003c\/li\u003e\n\u003cli\u003eIdentify standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.\u003c\/li\u003e\n\u003cli\u003eRecognize and address neurological complications associated with new cancer therapies.\u003c\/li\u003e\n\u003cli\u003eIdentify and manage long-term complications of CNS and PNS tumors and their treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e🧠 The \u003cstrong\u003eHarvard 3rd Annual Update in Neuro-Oncology 2023\u003c\/strong\u003e is best for \u003cstrong\u003eneurologists, oncologists, neurosurgeons, radiation oncologists, pathologists\u003c\/strong\u003e, and other healthcare professionals involved in the care of patients with \u003cstrong\u003ecentral and peripheral nervous system tumors\u003c\/strong\u003e. It’s ideal for:\u003cbr\u003e\u003ch3\u003e👩‍⚕️ Who Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eClinicians treating \u003cstrong\u003eprimary and metastatic brain and spine tumors\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eSpecialists managing \u003cstrong\u003eneurological complications of cancer\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eResearchers and educators seeking updates on \u003cstrong\u003emolecular neuropathology and neuroradiology\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e📅 \u003cstrong\u003eDates\u003c\/strong\u003e: July 26–28, 2023\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default open\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--title field-wrapper field field--name-field-hms-pdl-title field--type-string field--label-hidden field__items\"\u003e\n\u003ch4 class=\"field__item\"\u003eWednesday, July 26, 2023\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--items field-wrapper field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:00-10:10 AM \u003cstrong\u003eWelcome: Pediatric Neuro-Oncology Session \u003c\/strong\u003eMariella Filbin, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:10-10:40 AM \u003cstrong\u003eKeynote: CAR T Cell Therapy for Diffuse Midline Gliomas \u003c\/strong\u003eMichelle Monje,  MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:40-11:10 AM \u003cstrong\u003eWHO Classification, Pediatric CNS Tumors \u003c\/strong\u003eSanda Alexandrescu, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:10-11:40 AM \u003cstrong\u003eEmbryonal Tumors \u003c\/strong\u003eScott Pomeroy, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:40 AM-12:00 PM \u003cstrong\u003eBreak\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:00-12:30 PM \u003cstrong\u003ePediatric Low-Grade Gliomas \u003c\/strong\u003eSusan Chi, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:30-1:00 PM \u003cstrong\u003ePediatric High-Grade Gliomas \u003c\/strong\u003eMariella Filbin, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:00-1:30 PM \u003cstrong\u003eEpendymomas and Glioneuronal Tumors \u003c\/strong\u003ePratiti (Mimi) Bandopadhayay, MBBS, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:30-1:45 PM \u003cstrong\u003eLive Question \u0026amp; Answer Session \u003c\/strong\u003eMariella Filbin, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:45-2:00 PM \u003cb\u003eBreak\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:00-2:15 PM \u003cstrong\u003eChoroid Plexus Tumors \u003c\/strong\u003eViviana Benitez, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:15-2:30 PM \u003cstrong\u003ePineal Tumors \u003c\/strong\u003eShannon MacDonald, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:30-2:45 PM \u003cstrong\u003eGerm Cell Tumors \u003c\/strong\u003eAaron Yeo, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:45-3:15 PM \u003cstrong\u003eNeurofibromatosis \u003c\/strong\u003eScott Plotkin, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:15-3:30 PM \u003cstrong\u003eVon Hippel Lindau \u003c\/strong\u003eOthon Iliopoulos, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:30-3:45 PM \u003cstrong\u003eLive Question \u0026amp; Answer Session \u003c\/strong\u003eMariella Filbin, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:45-3:50 PM \u003cstrong\u003eAdjourn \u003c\/strong\u003eMariella Filbin, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default open\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--title field-wrapper field field--name-field-hms-pdl-title field--type-string field--label-hidden field__items\"\u003e\n\u003ch4 class=\"field__item\"\u003eThursday, July 27, 2023\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--items field-wrapper field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:00-10:05 AM \u003cstrong\u003eWelcome: Adult Neuro-Oncology \u003c\/strong\u003eTracy Batchelor, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:05-10:30 AM \u003cstrong\u003eKeynote: Surgical Immunotherapy Clinical Trials for Glioblastoma Multiforme (GBM) \u003c\/strong\u003eE. Antonio Chiocca, MD,PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:30-10:45 AM \u003cstrong\u003eAdvances in Surgery for Brain Tumors \u003c\/strong\u003eWilliam Curry, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:45-11:00 AM \u003cstrong\u003eAdvances in Imaging for Brain Tumors \u003c\/strong\u003eTina Young Poussaint, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:00-11:15 AM \u003cstrong\u003eAdvances in Radiation for Brain Tumors \u003c\/strong\u003eHelen Shih, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:15-11:25 AM \u003cstrong\u003eLive Question and Answer Session \u003c\/strong\u003eTracy Batchelor, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:25-11:30 AM \u003cb\u003eBreak\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:30 AM-12:00 PM \u003cstrong\u003eWHO Classification for Adult Gliomas \u003c\/strong\u003eDavid Louis, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:00-12:30 PM \u003cstrong\u003eGliomas, IDH-Mutant \u003c\/strong\u003e​​​​​Nicolas Gonzalez Castro, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:30-12:45 PM \u003cstrong\u003eGliomas, IDH-Wildtype \u003c\/strong\u003eIsabel Arrillaga,  MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:45-1:10 PM \u003cstrong\u003eAdvances in Experimental Therapies for Gliomas \u003c\/strong\u003eDavid Reardon, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:10-1:30 PM \u003cb\u003eBreak\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:30-1:45 PM \u003cstrong\u003eMeningioma \u003c\/strong\u003eWenya Linda Bi, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:45-2:00 PM \u003cstrong\u003eCNS Lymphomas \u003c\/strong\u003eLakshmi Nayak, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:00-2:15 PM \u003cstrong\u003ePituitary Tumors \u003c\/strong\u003ePamela Jones, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:15-2:45 PM \u003cstrong\u003eLive Question \u0026amp; Answer Session \u003c\/strong\u003eTracy Batchelor, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:45-2:50 PM \u003cstrong\u003eAdjourn\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default open\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--title field-wrapper field field--name-field-hms-pdl-title field--type-string field--label-hidden field__items\"\u003e\n\u003ch4 class=\"field__item\"\u003eFriday, July 28, 2023\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--items field-wrapper field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:00-10:05 AM \u003cstrong\u003eWelcome: Neurological Complications of Cancer \u003c\/strong\u003ePatrick Wen, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:05-10:30 AM \u003cstrong\u003eKeynote: Neural Regulation of Cancer \u003c\/strong\u003eHumsa Venkatesh, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:30-11:00 AM \u003cstrong\u003eMetastases to the Brain \u003c\/strong\u003ePriscilla Brastianos, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:00-11:15 AM \u003cstrong\u003eMetastases to the Leptomeninges \u003c\/strong\u003eRicky McFaline-Figueroa, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:15-11:30 AM \u003cstrong\u003eMetastases to the Epidural Space and Spinal Cord \u003c\/strong\u003eJohn Chi, MD, MPH\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:30-11:45 AM \u003cstrong\u003eLive Question and Answer Session \u003c\/strong\u003ePatrick Wen, MD\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:45 AM-12:15 PM \u003cb\u003eBreak\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:15-12:30 PM \u003cstrong\u003eParaneoplastic Neurological Syndromes \u003c\/strong\u003eEudocia Lee, MD, MPH\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:30-1:00 PM \u003cstrong\u003eCommon Neurological Complications in Cancer Patients \u003c\/strong\u003eUgonma Chukwueke, MD, MPH\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:00-1:15 PM \u003cstrong\u003eNeurological Complications of Cancer Immunotherapies \u003c\/strong\u003eJorg Dietrich, MD, PhD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:15-1:30 PM \u003cstrong\u003eManaging Long-Term Survivors of CNS Tumors \u003c\/strong\u003eDeborah Forst, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:30 – 1:45 PM \u003cstrong\u003eLive Question and Answer Session \u003c\/strong\u003ePatrick Wen, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:45-2:00 PM \u003cstrong\u003eClosing \u0026amp; Adjourn \u003c\/strong\u003eTracy Batchelor, MD, MPH\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954506403938,"sku":"MED-AMB04902","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-3rd-Annual-Update-in-Neuro-Oncology-2023.jpg?v=1779378401","url":"https:\/\/meducourse.com\/products\/harvard-3rd-annual-update-in-neuro-oncology-2023","provider":"Meducourse","version":"1.0","type":"link"}